Luque-Suarez A, Navarro-Ledesma S, Petocz P, Hancock M J, Hush J
Physiotherapy Department, University of Malaga, Malaga, Spain.
Man Ther. 2013 Dec;18(6):573-7. doi: 10.1016/j.math.2013.06.002. Epub 2013 Jul 4.
The first aim of this study was to investigate whether kinesiotaping (KT) can increase the acromiohumeral distance (AHD) in asymptomatic subjects in the short term. The second aim was to investigate whether the direction of kinesiotaping application influences AHD.
In recent years, the use of KT has become increasingly popular for a range of musculoskeletal conditions and for sport injuries. To date, we are unaware of any research investigating the effect of kinesiotaping on AHD. Moreover, it is unknown whether the direction of kinesiotaping application for the shoulder is important.
Forty nine participants were randomly assigned to one of three groups: kinesiotaping group 1 (KT1), kinesiotaping group 2 (KT2) and sham kinesiotaping (KT3). AHD ultrasound measurements at 0° and 60° of shoulder elevation were collected at baseline and immediately after kinesiotape application.
The results showed significant improvements in AHD after kinesiotaping, compared with sham taping. The mean difference in AHD between KT1 and KT3 groups was 1.28 mm (95% CI: 0.55, 2.03), and between KT2 and KT3 was 0.98 mm (95% CI: 0.23, 1.74). Comparison of KT1 and KT2 groups, which was performed to identify whether the direction of taping influences the AHD, indicated there were no significant differences.
KT increases AHD in healthy individuals immediately following application, compared with sham kinesiotape. No differences were found with respect to the direction in which KT was applied.
本研究的首要目的是调查肌内效贴布(KT)能否在短期内增加无症状受试者的肩峰肱骨间距(AHD)。第二个目的是调查肌内效贴布的应用方向是否会影响AHD。
近年来,肌内效贴布在一系列肌肉骨骼疾病和运动损伤中的应用越来越普遍。迄今为止,我们尚未发现任何关于肌内效贴布对AHD影响的研究。此外,尚不清楚肩部肌内效贴布的应用方向是否重要。
49名参与者被随机分配到三组中的一组:肌内效贴布组1(KT1)、肌内效贴布组2(KT2)和假肌内效贴布组(KT3)。在基线时以及贴上肌内效贴布后立即收集肩部抬高0°和60°时的AHD超声测量值。
结果显示,与假贴布相比,肌内效贴布应用后AHD有显著改善。KT1组和KT3组之间AHD的平均差异为1.28毫米(95%置信区间:0.55,2.03),KT2组和KT3组之间为0.98毫米(95%置信区间:0.23,1.74)。对KT1组和KT2组进行比较以确定贴布方向是否影响AHD,结果表明没有显著差异。
与假肌内效贴布相比,肌内效贴布在应用后能立即增加健康个体的AHD。在肌内效贴布的应用方向上未发现差异。